NEXENTIS TECHNOLOGIES INC. Stock Issued During Period, Shares, New Issues
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Stock Issued During Period, Shares, New Issues of 691.00 thousand shares for the 4-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-04-01
- 2023-12-31: .
- 2023-04-05: Stock Issued During Period, Shares, New Issues 166.34K shares; Stock Issued During Period, Shares, New Issues as first filed 1.16M shares.
- 2022-08-29: Stock Issued During Period, Shares, New Issues 0 month 429.00 shares.
- 2022-08-15: Stock Issued During Period, Shares, New Issues 0 month 228.57K shares; Stock Issued During Period, Shares, New Issues 0 month as first filed 1.60M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues as first filed | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 0 month as first filed | Stock Issued During Period, Shares, New Issues 4 month |
|---|---|---|---|---|---|
| 2023-12-31 | 691.00K shares 10-K · filed 2024-04-01 | ||||
| 2023-04-05 | 166.34K shares 10-Q · filed 2023-11-14 | 1.16M shares 10-Q · filed 2023-08-14 | |||
| 2022-08-29 | 429.00 shares 10-K · filed 2024-04-01 | ||||
| 2022-08-15 | 228.57K shares 10-K · filed 2024-04-01 | 1.60M shares 10-Q · filed 2023-08-14 | |||
| 2022-03-24 | 1.29K shares 10-K · filed 2024-04-01 | ||||
| 2021-05-13 | 155.84K shares 10-K · filed 2024-04-01 | 1.09M shares 10-Q · filed 2021-08-16 | |||
| 2018-04-29 | 200.00K shares 10-K · filed 2020-03-30 | ||||
| 2018-01-24 | 333.33K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |